Anthony Nicholas is a Neurology physician. OpenAlex indexes 103 publications with 5,879 citations (h-index 43).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
930 Madison Ave Ste 801
Memphis, TN 381033410
Telephone
901-866-8805Provider last certified this registry record 14 Jul 2025.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amneal Pharmaceuticals LLCProgram year20251 payment
- TerSera Therapeutics LLCProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
93.4%Aromatic Amino Acid Decarboxylation Inhibitor27.7%Carbidopa-Levodopa78%Carbidopa-Levodopa Er19%Carbidopa-Levodopa-Entacapone3%Part D<11 patientsBenzodiazepine17.9%Clonazepam88%Alprazolam12%Part D<11 patients+ 13 more classes in this area
Cardiovascular
4.3%Beta blocker4.3%Propranolol Hcl57%Propranolol Hcl Er43%Part D<11 patientsHormonal (systemic)
1.4%Mineralocorticoids1.4%Fludrocortisone Acetate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Establishing sustainable sediment budgets is critical for climate-resilient mega-deltas
Environmental Research Letters
2021 - Peptidylarginine Deiminase Inhibitors Reduce Bacterial Membrane Vesicle Release and Sensitize Bacteria to Antibiotic Treatment
Frontiers in Cellular and Infection Microbiology
2019 - Peptidylarginine Deiminases Post-Translationally Deiminate Prohibitin and Modulate Extracellular Vesicle Release and MicroRNAs in Glioblastoma Multiforme
International Journal of Molecular Sciences
2018
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”